MED12 and HMGA2 mutations: two independent genetic events in uterine leiomyoma and leiomyosarcoma

被引:116
作者
Bertsch, Elizabeth [1 ]
Qiang, Wenan [2 ]
Zhang, Qing [1 ,3 ]
Espona-Fiedler, Margarita [2 ]
Druschitz, Stacy [2 ]
Liu, Yu [2 ]
Mittal, Khush [4 ]
Kong, Beihua [3 ]
Kurita, Takeshi [2 ]
Wei, Jian-Jun [1 ,2 ]
机构
[1] Northwestern Univ, Dept Pathol, Feinberg Sch Med, Chicago, IL 60611 USA
[2] Northwestern Univ, Dept Obstet & Gynecol, Feinberg Sch Med, Chicago, IL 60611 USA
[3] Shandong Univ, Dept Gynecol & Obstet, Jinan 250100, Peoples R China
[4] NYU, Dept Pathol, Longue Med Sch, New York, NY 10016 USA
关键词
HMGA2; leiomyomas; leiomyosarcoma; MED12; UNITED-STATES; LONG ARM; INACTIVATION; CHROMOSOME-7; EXPRESSION; MYOMETRIUM; FIBROIDS; 12Q14-15;
D O I
10.1038/modpathol.2013.243
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Recent identification of somatic MED12 mutations in most uterine leiomyomas brings a new venue for the study of the tumorigenesis of leiomyomas. We are particularly interested in the correlation of MED12 and HMGA2 gene products in leiomyomas and leiomyosarcomas with and without MED12 mutations. To address these issues, in this study we examined MED12 mutations in a large cohort of usual type leiomyomas (178 cases) and uterine leiomyosarcomas (32 cases). We found that 74.7% (133/178) of leiomyomas had MED12 mutations, which was consistent with several independent studies. In contrast, only 9.7% (3/32) of leiomyosarcomas harbored MED12 mutations. Expression analysis by western blot and immunohistochemistry revealed that those leiomyomas with complex MED12 mutations had significantly lower protein products than the matched myometrium. Interestingly, most leiomyosarcomas without MED12 mutations also had very low levels of MED12 expression in comparison to the matched myometrium. These findings suggest a potential functional role of MED12 in both benign and malignant uterine smooth muscle tumors. When we further examined HMGA2 expression in all leiomyomas and leiomyosarcomas, we found that HMGA2 overexpression was exclusively present in those leiomyomas with no MED12 mutation, accounting for 10.1% (18/178) of total leiomyomas and 40% (18/45) of non-MED12 mutant leiomyomas. Twenty-five percent (8/32) of leiomyosarcomas had HMGA2 overexpression, and no MED12 mutations were found in HMGA2 positive leiomyosarcoma. These findings strongly suggest that MED12 mutations and HMGA2 overexpression are independent genetic events that occur in leiomyomas, and they may act differently in the tumorigenesis of uterine leiomyomas.
引用
收藏
页码:1144 / 1153
页数:10
相关论文
共 29 条
[1]   PROBLEMATIC UTERINE SMOOTH-MUSCLE NEOPLASMS - A CLINICOPATHOLOGICAL STUDY OF 213 CASES [J].
BELL, SW ;
KEMPSON, RL ;
HENDRICKSON, MR .
AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 1994, 18 (06) :535-558
[2]   Hysterectomy rates in the United States 1990-1997 [J].
Farquhar, CM ;
Steiner, CA .
OBSTETRICS AND GYNECOLOGY, 2002, 99 (02) :229-234
[3]  
Garcia-Torres R, 2000, NEPHROLOGIE, V21, P9
[4]   HMGA2 expression in uterine leiomyomata and myometrium:: Quantitative analysis and tissue culture studies [J].
Gross, KL ;
Neskey, DM ;
Manchanda, N ;
Weremowicz, S ;
Kleinman, MS ;
Nowak, RA ;
Ligon, AH ;
Rogalla, P ;
Drechsler, K ;
Bullerdiek, J ;
Morton, CC .
GENES CHROMOSOMES & CANCER, 2003, 38 (01) :68-79
[5]   HMGIC expressed in a uterine leiomyoma with a deletion of the long arm of chromosome 7 along with a 12q14-15 rearrangement but not in tumors showing del(7) as the sole cytogenetic abnormality [J].
Hennig, Y ;
Rogalla, P ;
Wanschura, S ;
Frey, G ;
Deichert, U ;
Bartnitzke, S ;
Bullerdiek, J .
CANCER GENETICS AND CYTOGENETICS, 1997, 96 (02) :129-133
[6]   Chromosomal translocations affecting 12q14-15 but not deletions of the long arm of chromosome 7 associated with a growth advantage of uterine smooth muscle cells [J].
Hennig, Y ;
Deichert, U ;
Bonk, U ;
Thode, B ;
Bartnitzke, S ;
Bullerdiek, J .
MOLECULAR HUMAN REPRODUCTION, 1999, 5 (12) :1150-1154
[7]   Expression profiling of uterine leiomyomata cytogenetic subgroups reveals distinct signatures in matched myometrium: transcriptional profiling of the t(12;14) and evidence in support of predisposing genetic heterogeneity [J].
Hodge, Jennelle C. ;
Kim, Tae-Min ;
Dreyfuss, Jonathan M. ;
Somasundaram, Priya ;
Christacos, Nicole C. ;
Rousselle, Marissa ;
Quade, Bradley J. ;
Park, Peter J. ;
Stewart, Elizabeth A. ;
Morton, Cynthia C. .
HUMAN MOLECULAR GENETICS, 2012, 21 (10) :2312-2329
[8]   Mutational analysis of MED12 exon 2 in uterine leiomyoma and other common tumors [J].
Je, Eun Mi ;
Kim, Mee Ran ;
Min, Ki Ouk ;
Yoo, Nam Jin ;
Lee, Sug Hyung .
INTERNATIONAL JOURNAL OF CANCER, 2012, 131 (06) :E1044-E1047
[9]   Somatic MED12 mutations in uterine leiomyosarcoma and colorectal cancer [J].
Kampjarvi, K. ;
Makinen, N. ;
Kilpivaara, O. ;
Arola, J. ;
Heinonen, H-R ;
Bohm, J. ;
Abdel-Wahab, O. ;
Lehtonen, H. J. ;
Pelttari, L. M. ;
Mehine, M. ;
Schrewe, H. ;
Nevanlinna, H. ;
Levine, R. L. ;
Hokland, P. ;
Bohling, T. ;
Mecklin, J-P ;
Butzow, R. ;
Aaltonen, L. A. ;
Vahteristo, P. .
BRITISH JOURNAL OF CANCER, 2012, 107 (10) :1761-1765
[10]   Rescue of platinum-damaged oocytes from programmed cell death through inactivation of the p53 family signaling network [J].
Kim, S-Y ;
Cordeiro, M. H. ;
Serna, V. A. ;
Ebbert, K. ;
Butler, L. M. ;
Sinha, S. ;
Mills, A. A. ;
Woodruff, T. K. ;
Kurita, T. .
CELL DEATH AND DIFFERENTIATION, 2013, 20 (08) :987-997